BIO-TECHNE Corp Restructuring Reserve, Settled without Cash
BIO-TECHNE Corp (TECH) reported Restructuring Reserve, Settled without Cash of $25.35 million for the 12-month period ending 2024-06-30, per its 10-K filed 2024-08-22.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2024-08-22
- BIO-TECHNE Corp restructuring reserve, settled without cash for the quarter ending 2024-03-31 was $843.00K.
- BIO-TECHNE Corp restructuring reserve, settled without cash for the quarter ending 2023-12-31 was $6.23M.
- BIO-TECHNE Corp restructuring reserve, settled without cash for the quarter ending 2021-09-30 was $0.00.
- BIO-TECHNE Corp restructuring reserve, settled without cash for fiscal 2024 was $25.35M.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 6 month | Restructuring Reserve, Settled without Cash 12 month |
|---|---|---|---|
| 2024-06-30 | $25.35M 10-K · filed 2024-08-22 | ||
| 2024-03-31 | $843.00K 10-Q · filed 2024-05-06 | $7.07M derived: sum of 2 quarters · filed 2024-05-06 | |
| 2023-12-31 | $6.23M 10-Q · filed 2024-05-06 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |